HCM is present in 1 in 500 individuals around the world. While most patients with HCM can have a normal lifestyle and longevity, there are important issues regarding family screening, sudden cardiac arrest risk, and therapies.

In this interview, Steve R. Ommen MD, FACC, and Matthew Martinez MD, FACC, discuss Hypertrophic Cardiomyopathy: Genetics, Natural History, Evolution and Septal Reduction Therapies.

Clinical Topics: Arrhythmias and Clinical EP, Heart Failure and Cardiomyopathies, SCD/Ventricular Arrhythmias, Acute Heart Failure, Anticoagulation Management, Noninvasive Imaging, Prevention

Keywords: ACCELLite, Heart Failure, Cardiomyopathy, Hypertrophic, Death, Sudden, Cardiac

< Back to Listings